influenza

  • Novartis supports influenza framework at World Health Assembly

    Novartis welcomes the decision to endorse the Pandemic Influenza Preparedness Framework (PIP Framework) at the sixty-fourth World Health Assembly. The PIP Framework sets out the roles and commitments of different stakeholders, including the World Hea…

    influenza | 19 May 2011

  • Phase two clinical trial for universal influenza vaccine

    BiondVax Pharmaceuticals announces that it has received the approvals of the Ethics (“Helsinki”) Committees of the Institutional Review Boards (IRB) of both the Hadassah Clinical Research Center at Hadassah University Hospital in Jerusalem (Hada…

    influenza | 08 September 2010

  • Award for work on universal influenza vaccine

    Frost & Sullivan announces the award of its 2010 European Influenza Vaccines Technology Innovation Award to BiondVax Pharmaceuticals for their breakthrough work on a universal influenza vaccine. This vaccine, the Multimeric-001, is designed to provi…

    influenza | 02 August 2010

  • Potential supply of influenza vaccine for Southeast Asia

    Cytos Biotechnology and Agency for Science, Technology and Research (A*STAR) announce their first collaboration on a virus-like particle (VLP) vaccine. This partnership, which involves academic and clinical partners across Singapore, aims at res…

    influenza | 22 July 2010

  • Rare anti-influenza antibodies

    Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work wa…

    influenza | 01 July 2010

  • HKU Found Drug to Treat Influenza

    While Influenza A remains a significant public health challenge, the rising of antiviral resistance in influenza virus making many drugs not working well leads to a even bigger threat to mankind. A research team at the University of Hong Kong dis…

    influenza | 09 June 2010

  • PPD and Southern Research Institute Sign Agreement for Clinical Research Services

    PPD and Southern Research Institute have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development. This is to provide clients a full spectrum of influenza vaccine development services by collaborating on cl…

    influenza | 24 March 2010

  • Treating H1N1: Innovation Behind the Science

    Information technology aids in the prediction of drug development trends.

    influenza | 01 October 2009

  • GlaxoSmithKline: Government Orders for Pandemic (H1N1) 2009 Vaccine

    GlaxoSmithKline (GSK) has confirmed that it has contracts in place to supply 195 million doses of its pandemic (H1N1) 2009 adjuvanted influenza vaccine. It has a variety of agreements in place with the US government to supply pandemic products worth …

    influenza | 10 August 2009

  • Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry

    With the outbreak of H1N1 influenza in several countries, people are aware of the importance of vaccine. According to Frost & Sullivan's research in the Chinese vaccine market, the Compound Annual Growth Rate (CAGR) of the pharmaceutical industry…

    influenza | 26 June 2009

Page 1 Next > Last >>